No products in the cart.
Regorafenib Tablets
$1.00
Regorafenib (Reodixin®) is an oral multi-kinase inhibitor targeting angiogenesis, proliferation, metastasis, and tumor immunity. FDA-approved for several advanced solid tumors. Here offered as 40mg tablets in a 28-count bottle—strictly for laboratory research use only
Description
Regorafenib Tablets Product Specifications
| Attribute | Details |
|---|---|
| Product Name | Regorafenib Tablets |
| Strength | 40mg per tablet |
| Quantity | 28 tablets per bottle |
| Dosage Form | Oral film-coated tablet |
| Approval No. | China NMPA H20243057 |
| Product Code | 86900647000343 |
| Manufacturer | Shanghai Chuannuo Pharmaceutical Co., Ltd. |
| Intended Use | Laboratory research use only—Not for human or veterinary use |
Overview & Mechanism
Regorafenib is a potent multi-kinase inhibitor that targets RTKs critical to tumor growth: VEGFR1/2/3, TIE2, PDGFR, FGFR, KIT, RET, RAF1, BRAF, and CSF1R. It suppresses angiogenesis, proliferation, metastasis, and modulates the tumor immune microenvironment sciencedirect.comoncologynewscentral.com+5stivarga.com+5stivargahcp.com+5de.wikipedia.org+2pmc.ncbi.nlm.nih.gov+2stivargahcp.com+2.
Research & Clinical Background
FDA-approved for metastatic colorectal cancer, GIST, and hepatocellular carcinoma
Shown to extend median overall survival in metastatic colorectal cancer (CORRECT, CONCUR trials) by ~1.4–2.5 months
Demonstrates broad signaling pathway inhibition, including anti-angiogenic and immunomodulatory effects
Research Applications
Ideal for use in:
Angiogenesis and TME modeling
Kinase signaling pathway assays
Drug resistance and combination studies
Metastasis and proliferation models
Pharmacodynamic and bioactivity profiling
Research-Use Disclaimer
This product is provided strictly for laboratory research and development use only.
Additional information
| Weight | 1.1 kg |
|---|---|
| Dimensions | 26 × 28 × 26 cm |
1 review for Regorafenib Tablets
Related products
Palbociclib Capsules (Xipeilai)
Palbociclib Capsules (Research Grade) in 125mg strength, 21-count bottle. Supplied by Shanghai Chuannuo Pharmaceutical Co., Ltd. For investigational or research applications only—not for human consumption or therapeutic use.
$2.00Fulvestrant Faslodex
Fluvestrant (250mg/5ml) injectable solution, 2-vial set by EVER?Pharma Jena GmbH, Germany. A potent selective estrogen receptor degrader (SERD) used in advanced breast cancer research. $2.00Reduced Glutathione Injection
Ruiyang Reduced Glutathione Injection (0.6g per vial × 10) by Ruiyang Pharmaceutical Co., Ltd. Ideal for antioxidant, detoxification, and hepatic-protection research in metabolic and oxidative stress studies. $2.00Mechlorethamine Hydrochloride Injection
Mechlorethamine hydrochloride (HaiPu®) is a potent DNA-alkylating agent from the nitrogen mustard class, supplied as a 1mL vial containing 5mg. Manufactured by Shanghai Xudong Haipu Pharmaceutical Co., Ltd., with NMPA approval H31020897 and product code 86900808000625. Strictly for laboratory research use.Please consult the staff for other purposes. $1.00
yaser –
Das Paket ist angekommen, danke